If you feel your psoriasis treatment is not producing what you seek here are 10 key factors that might be hindering your ...

Key findings of subgroup analyses included an observed increased psoriasis risk in patients without atopic comorbidities (HR 1.42, 95% CI 1.06-1.89) and those with pretreatment immunoglobulin E (IgE) ...

About one-third of psoriasis sufferers develop psoriatic arthritis, with swelling, tenderness and pain in joints, affecting daily activities and lifestyle. Psoriatic arthritis (PsA) is a chronic ...

"It's not just taking something away, but really doing a careful assessment of how that medication works within that ...

Topical ruxolitinib cream shows promise as a treatment for inflammatory skin conditions, but lacks consistent data, indicating a need for further research into its use across various dermatologic ...

Plaque psoriasis, the most common form of the disease, affects approximately 6 million Americans and is characterized by lesions topped with silvery white scales (National Psoriasis Foundation ...

This article explores the complex roles of cytokine networks in the development and progression of autoimmune diseases.

FRONTIER 2 included a range of JNJ-2113 doses, with the most effective (100 mg given twice-daily) achieving a 76% PASI 75 response – 78.6% clearance of psoriasis skin lesions – at 52 weeks.

With skin cancer on the rise across the UK, Boots is expanding dermatology training for its in-store pharmacists. Matt Nixson ...

Those include having a Psoriasis Area and Severity Index (PASI) of 10 or more – indicating that lesions cover at least 10% of their body – and a Dermatology Life Quality Index (DLQI ...

Circular rashes may be puzzling—and alarming. The instant most individuals catch sight of a circle or ring-shaped area on the ...

Compared with other systemic agents for treating atopic dermatitis, dupilumab is associated with an increased risk for ...